Case Report: Prognostic evaluation of immunotherapy in two patients with SMARCA4-UT using TCR as a new marker
Thoracic SMARCA4-deficient undifferentiated tumour(SMARCA4-UT) is a newly classified subgroup of non-small cell lung cancer (NSCLC) that is rare and associated with a poor prognosis. There is a paucity of robust research regarding its treatment options…